Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri

Area of Science:

• Natural Product Chemistry
• Virology
• Molecular Biology

Background:

• The Human Immunodeficiency Virus (HIV) Rev protein is essential for viral replication.
• Inhibiting the interaction between Rev protein and its RNA target (RRE) is a potential antiviral strategy.
• Phyllanthus niruri L. is a plant source of various bioactive compounds.

Purpose of the Study:

• To isolate and characterize novel natural products with potential anti-HIV activity.
• To evaluate the inhibitory effect of isolated compounds on HIV-Rev/RRE binding.
• To assess the antiviral efficacy of identified compounds in cell-based assays.

Main Methods:

• Bioassay-guided fractionation of Phyllanthus niruri L. MeOH extract.
• Structure elucidation of isolated compounds using spectroscopic methods.
• In vitro assay to measure inhibition of HIV-Rev binding to RRE RNA.
• XTT dye reduction assay to evaluate protection of CEM-SS cells from HIV infection.

Main Results:

• Niruriside (1) was isolated from Phyllanthus niruri L. and its structure determined.
• Niruriside demonstrated specific inhibitory activity against HIV-Rev/RRE binding with an IC50 of 3.3 microM.
• Niruriside did not exhibit protective effects against acute HIV infection in CEM-SS cells up to 260 microM.

Conclusions:

• Niruriside is a novel inhibitor of the HIV-Rev/RRE interaction.
• Despite inhibiting Rev-RRE binding, niruriside lacks significant antiviral activity in this cell model.
• Further research may explore niruriside derivatives or other mechanisms for anti-HIV drug development.